Capricor Therapeutics (CAPR) 10-K2019 FY Annual report

Filed: 27 Mar 20, 8:31am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: aim, anin, ANOVA, applica, arisen, assay, atrium, atrophy, bacteria, binary, binding, biodistribution, bioequivalence, biomolecular, breaking, cargo, catheter, China, confirmedin, conventional, cytosol, deviation, distal, distant, effector, efficacyof, elicit, EMA, evidencing, expiratory, familiar, Governor, Graft, grip, GVHD, home, humoral, hypersensitivity, immunogenic, immunogenicity, incremental, inherited, inour, inspiratory, intercellular, intranasal, intrathecal, ITT, Lastly, leverage, load, lot, lyophilization, macrophage, membrane, mesenchymal, mixed, mRNA, MSC, nucleic, null, orunanticipated, Ourexosome, outbreak, overnight, partnership, pave, peak, penny, perspective, phenotypic, pinch, pink, podium, polarization, potency, preferential, purified, Qualification, reaction, recapitulating, reclassifying, repriced, repricing, satellite, sequencing, signal, solved, spleen, spread, stability, strength, strong, subconjunctival, synthesized, synthetically, temporary, tighter, tip, tool, transport, unblinded, unchanged, unproven, unsure, uptake, USAISR, vaccine, vesicle, vitro, vivo, widespread, winding

Removed: accredited, acquired, acute, adjacent, advisory, applying, Ascheim, assigned, Baltimore, beneficially, bioactive, Canada, cardiology, cardiovascular, chronic, closely, Codification, collaborate, complied, conclusion, congruent, consecutive, contractile, counsel, crossing, Deborah, deem, deliverable, died, Digital, dilated, dimensional, directionally, doubt, durability, easier, encouraging, enrolled, essentially, fibrillation, foundation, Harry, healing, highest, immunologic, Importantly, Index, infarct, inflammatory, infusing, innovation, intervene, ischemic, Johnson, Lit, location, Maryland, Mayo, measurable, median, mediator, Medtronic, memorializing, merged, mortgage, moved, natriuretic, nonrefundable, NYHA, occurred, opposition, origin, originated, packing, peptide, permanently, powered, practicable, prepare, primitive, progenitor, prompt, randomization, ratably, reassign, renewed, repayment, resell, Seventeen, shareholder, son, standalone, stratified, subprime, subscription, substantive, Subtopic, sudden, survive, tachycardia, therewith, TPE, triple, undelivered, unexercised, untested, VSOE, York

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated CAPR transcripts

CAPR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Anthony J. Bergmann, the Principal Financial Officer of Capricor Therapeutics, Inc. (the “Company”), hereby certifies, to his knowledge, that:

(1) the Annual Report on Form 10-K of the Company for the period ended December 31, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by the Report.

Date: March 26, 2020

/s/ Anthony J. Bergmann

Name: Anthony J. Bergmann

Title: Chief Financial Officer and Principal Financial Officer